
Jake Minh Vu
Examiner (ID: 8807, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1117 |
| Issued Applications | 361 |
| Pending Applications | 132 |
| Abandoned Applications | 637 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7040505
[patent_doc_number] => 20050159395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'NSAID-containing topical formulations that demonstrate chemopreventive activity'
[patent_app_type] => utility
[patent_app_number] => 11/037224
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6727
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037224 | NSAID-containing topical formulations that demonstrate chemopreventive activity | Jan 18, 2005 | Abandoned |
Array
(
[id] => 5215659
[patent_doc_number] => 20070104740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Self-microemulsifying drug delivery systems of a hiv protease inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/596738
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13117
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596738 | Self-microemulsifying drug delivery systems of a hiv protease inhibitor | Dec 22, 2004 | Abandoned |
Array
(
[id] => 5182628
[patent_doc_number] => 20070053974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Stable oral composition'
[patent_app_type] => utility
[patent_app_number] => 10/583842
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4198
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583842 | Stable oral composition | Dec 22, 2004 | Issued |
Array
(
[id] => 7193491
[patent_doc_number] => 20050163842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Rosiglitazone and metformin formulations'
[patent_app_type] => utility
[patent_app_number] => 11/021562
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27725
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163842.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021562 | Rosiglitazone and metformin formulations | Dec 22, 2004 | Abandoned |
| 11/016683 | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain | Dec 16, 2004 | Abandoned |
Array
(
[id] => 5215714
[patent_doc_number] => 20070104795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Multiphase active ingredient formulation'
[patent_app_type] => utility
[patent_app_number] => 10/583302
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5882
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583302 | Multiphase active ingredient formulation | Dec 14, 2004 | Abandoned |
Array
(
[id] => 7168197
[patent_doc_number] => 20050201974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Bioadhesive polymers with catechol functionality'
[patent_app_type] => utility
[patent_app_number] => 11/009327
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201974.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009327 | Bioadhesive polymers with catechol functionality | Dec 8, 2004 | Abandoned |
Array
(
[id] => 7250517
[patent_doc_number] => 20050142193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Galantamine formulations'
[patent_app_type] => utility
[patent_app_number] => 11/001609
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6066
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142193.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001609 | Galantamine formulations | Nov 30, 2004 | Abandoned |
Array
(
[id] => 7688786
[patent_doc_number] => 20070105912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Pharmaceutical compositions comprising lercanidipine'
[patent_app_type] => utility
[patent_app_number] => 10/581128
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21105
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581128 | Pharmaceutical compositions comprising lercanidipine | Nov 30, 2004 | Abandoned |
Array
(
[id] => 5193563
[patent_doc_number] => 20070082047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Solid preparation'
[patent_app_type] => utility
[patent_app_number] => 10/578136
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10609
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578136 | Solid preparation | Nov 3, 2004 | Abandoned |
Array
(
[id] => 7127963
[patent_doc_number] => 20050059707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Stabilization of retinoid compounds'
[patent_app_type] => utility
[patent_app_number] => 10/972568
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2721
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972568 | Stabilization of retinoid compounds | Oct 24, 2004 | Abandoned |
Array
(
[id] => 5204596
[patent_doc_number] => 20070026077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component'
[patent_app_type] => utility
[patent_app_number] => 10/575986
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575986
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575986 | Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component | Oct 13, 2004 | Abandoned |
Array
(
[id] => 7168179
[patent_doc_number] => 20050201972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery'
[patent_app_type] => utility
[patent_app_number] => 10/962204
[patent_app_country] => US
[patent_app_date] => 2004-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24128
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962204
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962204 | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery | Oct 6, 2004 | Issued |
Array
(
[id] => 7010295
[patent_doc_number] => 20050064011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Implantable or insertable medical devices containing phenolic compound for inhibition of restenosis'
[patent_app_type] => utility
[patent_app_number] => 10/955368
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7479
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10955368
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/955368 | Implantable or insertable medical devices containing phenolic compound for inhibition of restenosis | Sep 29, 2004 | Abandoned |
Array
(
[id] => 7163486
[patent_doc_number] => 20050085498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate'
[patent_app_type] => utility
[patent_app_number] => 10/947054
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19504
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10947054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/947054 | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate | Sep 20, 2004 | Abandoned |
Array
(
[id] => 6938638
[patent_doc_number] => 20050112201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Delayed release dosage forms'
[patent_app_type] => utility
[patent_app_number] => 10/943356
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17564
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943356
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943356 | Delayed release dosage forms | Sep 16, 2004 | Issued |
Array
(
[id] => 6911883
[patent_doc_number] => 20050175641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Percutaneous and perungual delivery system'
[patent_app_type] => utility
[patent_app_number] => 10/941054
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6156
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10941054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/941054 | Percutaneous and perungual delivery system | Sep 9, 2004 | Abandoned |
Array
(
[id] => 5601841
[patent_doc_number] => 20060292186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs'
[patent_app_type] => utility
[patent_app_number] => 10/569316
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7874
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569316 | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs | Aug 26, 2004 | Abandoned |
Array
(
[id] => 5193474
[patent_doc_number] => 20070081958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Body care product containing porous silver particles'
[patent_app_type] => utility
[patent_app_number] => 10/570230
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4514
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20070081958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570230 | Body care product containing porous silver particles | Aug 25, 2004 | Abandoned |
Array
(
[id] => 6982909
[patent_doc_number] => 20050152979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Hydrophobic drug compositions containing reconstitution enhancer'
[patent_app_type] => utility
[patent_app_number] => 10/925797
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5992
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10925797
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/925797 | Hydrophobic drug compositions containing reconstitution enhancer | Aug 24, 2004 | Abandoned |